Page 122 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk
P. 122
CHAPTER 6
In total three patients were indicated for a statin at baseline, but not anymore after four weeks and two patients did not need statins at baseline, but did after four weeks. Six patients had an antihypertensive indication at baseline and two doses optimization, but not at four weeks and two patients needed antihypertensives based at the values of four weeks, but not at baseline. This included one patient who was indicated for a statin and an antihypertensive at baseline, but not after four weeks, and one patient the other way around. In conclusion, in 13 (13.4%) patients the advice for (adaptations of) preventive treatment changed during the first four weeks of anti-rheumatic treatment.
Figure 1. Number of patients that changed from cardiovascular risk score category, during the first month of anti-rheumatic treatment, according to the Dutch SCORE (A) and European Heart SCORE (B), n=97
A. A.
B.
Stuart-maxwell analyses for Dutch SCORE, p=0.247.
B.
A.
Stuart-maxwell analyses for Heart SCORE risk score, p=0.135.
A.
120
B.
